PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105
NCT03278275
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
116
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
One injection of 68Ga-NOTA-AE105
DEVICE:
PET/CT
Sponsor
Rigshospitalet, Denmark